CIK: 0001595851 · Show all filings
Period: Q3 2024 (← Previous)
Filing Date: Nov 14, 2024
Total Value ($000): $331,044 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| XBI | SPDR SER TR | 300,000 | $29,640 | 9.0% | — | — | PUT | 78464A870 |
| — | BIOHAVEN LTD | 348,778 | $17,428 | 5.3% | $49.97 | — | CALL | G1110E907 |
| NVO | NOVO-NORDISK A S | 110,000 | $13,098 | 4.0% | $119.07 | — | ADR | 670100205 |
| EWTX | EDGEWISE THERAPEUTICS INC | 195,000 | $5,205 | 1.6% | $19.89 | 0.0% | COM | 28036F105 |
| CRBP | CORBUS PHARMACEUTICALS HLDGS | 220,000 | $4,539 | 1.4% | $36.40 | +40.6% | PUT | 21833P301 |
| DYN | DYNE THERAPEUTICS INC | 100,000 | $3,592 | 1.1% | $39.80 | 0.0% | COM | 26818M108 |
| CRVS | CORVUS PHARMACEUTICALS INC | 500,000 | $2,640 | 0.8% | $3.59 | 0.0% | COM | 221015100 |
| ABSI | ABSCI CORPORATION | 550,000 | $2,101 | 0.6% | $3.98 | 0.0% | COM | 00091E109 |
| CAPR | CAPRICOR THERAPEUTICS INC | 125,000 | $1,901 | 0.6% | $4.95 | 0.0% | COM NEW | 14070B309 |
| SMMT | SUMMIT THERAPEUTICS INC | 85,000 | $1,862 | 0.6% | $13.98 | 0.0% | COM | 86627T108 |
| LRMR | LARIMAR THERAPEUTICS INC | 200,000 | $1,310 | 0.4% | $8.04 | 0.0% | COM | 517125100 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 325,000 | $1,053 | 0.3% | $2.25 | 0.0% | COM | 03237H101 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | BLUEPRINT MEDICINES CORP | 140,000 (+250.0%) | $12,950 (+200.4%) | 3.9% | $93.17 | — | COM | 09627Y109 |
| JANX | JANUX THERAPEUTICS INC | 190,000 (+280.0%) | $8,632 (+312.1%) | 2.6% | $44.41 | -2.0% | COM | 47103J105 |
| SRPT | SAREPTA THERAPEUTICS INC | 120,000 (+118.2%) | $14,987 (+72.5%) | 4.5% | $121.31 | +14.0% | COM | 803607100 |
| TARS | TARSUS PHARMACEUTICALS INC | 350,000 (+48.9%) | $11,512 (+80.2%) | 3.5% | $22.72 | +23.7% | COM | 87650L103 |
| VKTX | VIKING THERAPEUTICS INC | 140,000 (+47.4%) | $8,863 (+76.0%) | 2.7% | $52.36 | +12.1% | COM | 92686J106 |
| ANNX | ANNEXON INC | 650,000 (+109.7%) | $3,848 (+153.3%) | 1.2% | $5.57 | +6.5% | COM | 03589W102 |
| ARVN | ARVINAS INC | 145,000 (+93.3%) | $3,571 (+78.9%) | 1.1% | $26.75 | -2.4% | COM | 04335A105 |
| TSHA | TAYSHA GENE THERAPIES INC | 2,150,000 (+72.0%) | $4,322 (+54.3%) | 1.3% | $2.17 | +1.1% | COM SHS | 877619106 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 450,000 (+28.6%) | $8,663 (+20.6%) | 2.6% | $21.33 | -3.1% | COM | 87164F105 |
| TNYA | TENAYA THERAPEUTICS INC | 1,500,000 (+11.1%) | $2,895 (-30.8%) | 0.9% | $4.34 | -34.9% | COM | 87990A106 |
| INSM | INSMED INC | 75,000 (+15.4%) | $5,475 (+25.7%) | 1.7% | $34.09 | +116.4% | COM PAR $.01 | 457669307 |
| RZLT | REZOLUTE INC | 1,474,995 (+3.8%) | $7,154 (+17.0%) | 2.2% | $3.48 | +32.0% | COM NEW | 76200L309 |
| BBIO | BRIDGEBIO PHARMA INC | 175,000 (+25.0%) | $4,456 (+25.6%) | 1.3% | $26.67 | -1.6% | COM | 10806X102 |
| RGNX | REGENXBIO INC | 265,000 (+55.9%) | $2,780 (+39.8%) | 0.8% | $15.36 | -20.7% | COM | 75901B107 |
| KRRO | KORRO BIO INC | 110,000 (+10.0%) | $3,676 (+8.5%) | 1.1% | $54.05 | -22.1% | COM | 500946108 |
| NUVB | NUVATION BIO INC | 1,350,000 (+17.4%) | $3,092 (-7.9%) | 0.9% | $3.05 | -0.0% | COM CL A | 67080N101 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BHVN | BIOHAVEN LTD | 490,000 | $17,008 | 5.1% | $35.01 | +11.1% | — | G1110E107 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 68,400 | $16,621 | 5.0% | $168.43 | +54.6% | PUT | 02043Q107 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 22,500 | $5,468 | 1.7% | $168.43 | +54.6% | — | 02043Q107 |
| ACAD | ACADIA PHARMACEUTICALS INC | 225,000 | $3,656 | 1.1% | $25.31 | -34.1% | — | 004225108 |
| CABA | CABALETTA BIO INC | 370,899 | $2,774 | 0.8% | $19.60 | -70.5% | — | 12674W109 |
| CYTK | CYTOKINETICS INC | 33,200 | $1,799 | 0.5% | $57.33 | -2.8% | — | 23282W605 |
| — | ELEVATION ONCOLOGY INC | 600,000 | $1,620 | 0.5% | $3.71 | — | — | 28623U101 |
| KRYS | KRYSTAL BIOTECH INC | 8,500 | $1,561 | 0.5% | $117.03 | +64.8% | — | 501147102 |
| ANNX | ANNEXON INC | 214,500 | $1,051 | 0.3% | $5.57 | +6.5% | CALL | 03589W102 |
| WVE | WAVE LIFE SCIENCES LTD | 200,000 | $998 | 0.3% | $5.70 | +4.8% | — | Y95308105 |
| — | RAPT THERAPEUTICS INC | 300,000 | $915 | 0.3% | — | — | CALL | 75382E109 |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | 35,000 | $910 | 0.3% | $31.99 | -23.7% | — | 04280A100 |
| SGMT | SAGIMET BIOSCIENCES INC | 225,000 | $770 | 0.2% | $7.18 | -57.1% | — | 786700104 |
| — | INTRA-CELLULAR THERAPIES INC | 10,000 | $685 | 0.2% | $68.49 | — | — | 46116X101 |
| MGNX | MACROGENICS INC | 150,000 | $638 | 0.2% | $9.74 | -60.0% | — | 556099109 |
| PMVP | PMV PHARMACEUTICALS INC | 375,000 | $608 | 0.2% | $6.13 | -74.8% | — | 69353Y103 |
| PTCT | PTC THERAPEUTICS INC | 19,000 | $581 | 0.2% | $32.39 | +3.3% | — | 69366J200 |
| — | REVANCE THERAPEUTICS INC | 225,000 | $578 | 0.2% | $21.62 | — | — | 761330109 |
| NTLA | INTELLIA THERAPEUTICS INC | 25,000 | $560 | 0.2% | $27.78 | -17.0% | — | 45826J105 |
| ANTX | AN2 THERAPEUTICS INC | 219,331 | $472 | 0.1% | $10.88 | -84.1% | — | 037326105 |
| CTMX | CYTOMX THERAPEUTICS INC | 300,000 | $366 | 0.1% | $1.85 | -31.2% | — | 23284F105 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| INSM | INSMED INC | 50,000 (-75.0%) | $3,650 (-72.8%) | 1.1% | $34.09 | +116.4% | CALL | 457669307 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 128,411 (-57.2%) | $6,474 (-50.9%) | 2.0% | $45.36 | +3.3% | CLASS A ORD | 61559X104 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 75,000 (-87.2%) | $1,706 (-77.7%) | 0.5% | $19.55 | -16.4% | COM | 92790C104 |
| SLNO | SOLENO THERAPEUTICS INC | 150,000 (-50.0%) | $7,574 (-38.1%) | 2.3% | $37.99 | +26.0% | COM | 834203309 |
| CRBP | CORBUS PHARMACEUTICALS HLDGS | 160,000 (-8.6%) | $3,301 (-58.3%) | 1.0% | $36.40 | +40.6% | COM NEW | 21833P301 |
| SYRE | SPYRE THERAPEUTICS INC | 60,000 (-76.0%) | $1,765 (-70.0%) | 0.5% | $31.83 | -12.5% | COM NEW | 00773J202 |
| ASND | ASCENDIS PHARMA A/S | 52,500 (-39.5%) | $7,839 (-33.7%) | 2.4% | $136.38 | — | SPONSORED ADR | 04351P101 |
| APLS | APELLIS PHARMACEUTICALS INC | 65,000 (-51.9%) | $1,875 (-63.8%) | 0.6% | $63.06 | -41.3% | COM | 03753U106 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 150,000 (-37.5%) | $7,665 (-28.7%) | 2.3% | $35.29 | +46.2% | COM | 22663K107 |
| ENGN | ENGENE HOLDINGS INC | 160,898 (-61.7%) | $1,062 (-73.2%) | 0.3% | $12.55 | -40.7% | COM | 29286M105 |
| PCVX | VAXCYTE INC | 80,000 (-46.7%) | $9,142 (-19.3%) | 2.8% | $51.35 | +75.5% | COM | 92243G108 |
| TGTX | TG THERAPEUTICS INC | 310,000 (-38.0%) | $7,251 (-18.5%) | 2.2% | $15.64 | +39.6% | COM | 88322Q108 |
| ROIV | ROIVANT SCIENCES LTD | 800,000 (-20.0%) | $9,232 (-12.7%) | 2.8% | $10.26 | +10.9% | SHS | G76279101 |
| CGON | CG ONCOLOGY INC | 250,000 (-3.8%) | $9,433 (+14.9%) | 2.8% | $36.44 | -3.8% | COM | 156944100 |
| SVRA | SAVARA INC | 725,000 (-31.0%) | $3,074 (-27.4%) | 0.9% | $4.36 | +1.2% | COM | 805111101 |
| CATX | PERSPECTIVE THERAPEUTICS INC | 750,000 (-18.9%) | $10,013 (+8.6%) | 3.0% | $14.46 | -8.0% | COM NEW | 46489V302 |
| IMVT | IMMUNOVANT INC | 215,000 (-17.3%) | $6,130 (-10.7%) | 1.9% | $32.31 | -8.7% | COM | 45258J102 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 78,842 (-32.8%) | $4,131 (-14.3%) | 1.2% | $43.76 | +9.5% | COM | 76243J105 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 375,000 (-37.5%) | $6,780 (+9.7%) | 2.0% | $11.64 | +20.0% | COM | 71722W107 |
| NGNE | NEUROGENE INC | 50,000 (-28.6%) | $2,098 (-17.6%) | 0.6% | $34.60 | +12.1% | COM | 64135M105 |
| OLMA | OLEMA PHARMACEUTICALS INC | 535,000 (-2.7%) | $6,388 (+7.3%) | 1.9% | $11.59 | +10.3% | COM | 68062P106 |
| PRQR | PROQR THRAPEUTICS N V | 887,700 (-1.4%) | $1,616 (+8.1%) | 0.5% | $1.94 | -3.3% | SHS EURO | N71542109 |
| AXSM | AXSOME THERAPEUTICS INC | 135,000 (-10.0%) | $12,132 (+0.5%) | 3.7% | $54.36 | +60.6% | COM | 05464T104 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| REPL | REPLIMUNE GROUP INC | 450,000 | $4,932 | 1.5% | $10.29 | -1.3% | COM | 76029N106 |
| ATYR | ATYR PHARMA INC | 800,000 | $1,408 | 0.4% | $1.74 | +4.4% | COM NEW | 002120202 |
| BBOT | HELIX ACQUISITION CORP II | 300,000 | $3,135 | 0.9% | $10.35 | +0.1% | CL A ORD SHS | G4444H101 |